Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...

Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report its Q1 2025 earnings on April 16. Wall Street analysts expect the company ...

Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures, and sells healthcare products. Its business segments ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...

Associate Director - New Product Introduction and Therapy Area Strategy, has tendered her resignation from employment of the ...

One of the largest healthcare companies in India, Abbott sells a wide range of products, including medicines, nutrition, ...